Loneliness: Surgeon General Dr. Murthy’s warning
Amrit Kahlon, M.D., Adil Khan, M.D., Steven Lippmann, M.D. […]
Age and antisuicidal effect of lithium
Leo Sher, M.D. Our research work, “Antisuicidal effect of lithium in bipolar patients: Is there an age-specific effect?” has been published in the Journal of Affective Disorders online ahead of print (1). The age-related antisuicidal effect of lithium and valproate was compared in ninety-four (n = 94) high-risk bipolar suicide attempters. Individuals with bipolar disorder […]
Suicide rates in the United States in 2022
Leo Sher, M.D. Three days ago, U.S. Centers for Disease Control and Prevention (CDC) released provisional data on suicide rates in the U.S. in 2022 (1). More people died by suicide in the U.S. in 2022 than any other year on record. Overall, 49,449 Americans (39,255 men and 10,194 women) died by suicide in 2022, […]
Intranasal esketamine ought to be more widely available
Steven Lippmann, M.D. There are concerns nation-wide about not having the latest interventional psychiatric treatment options available for clinical prescribing. For just one single example, intranasal esketamine is not uniformly present in some healthcare formularies. There are instances where financial, clinical, and/or other administrative hurdles block this new pharmacotherapy even to hospital emergency medicine departments. […]
Obesity is associated with increased risk for psychiatric disorders
Leo Sher, M.D. A research report, “Obesity as pleiotropic risk state for metabolic and mental health throughout life” has recently been published in Translational Psychiatry (1). A significant part of the worldwide population is overweight. Obesity is a substantial global health burden. The prevalence rates of obesity have been progressively increasing over the past decades. […]
Kratom – what ?: another widely available opioid… should it be ?… should it be regulated ?… what to do?
Steven Lippmann, M.D. I bet that most of you have never heard of kratom. Well, it is an opioid type of drug widely available in this country with little restriction … yes, surprising ! Already used by millions of people, its widening distribution is again in the news recently as a public health hazard and […]
DHEA and DHEAS blood levels in combat veterans with or without a history of suicide attempt
Leo Sher, M.D. Our research work, “Dehydroepiandrosterone and dehydroepiandrosterone sulfate levels in combat veterans with or without a history of suicide attempt” was published 5 years ago, in the July 2018 issue of Acta Psychiatrica Scandinavica (1). Demographic and clinical parameters of combat veterans who have made a suicide attempt postdeployment and combat veterans who […]
A study of depressed patients with or without comorbid alcohol use disorder
Leo Sher, M.D. Our research work, “Depressed patients with co-occurring alcohol use disorders: a unique patient population” was published 15 years ago, in the June 2008 issue of the Journal of Clinical Psychiatry (1). We compared depressed patients with or without comorbid alcohol use disorder with respect to demographic and clinical parameters. 505 individuals were […]
Seeking a cure for Alzheimer’s Disease: Donanemab?
Chase Bauman, B.S., B.A., Steven Lippmann, M.D. Is Alzheimer’s Disease bad? Yes, … it robs people of cognitive abilities, global function, gait, and can induce depressive and/or paranoid features. Do we want to cure? Yes, … but we want one that is effective, safe, available, affordable, and approved by regulatory authorities after a thorough scientific […]
So what we know about Juneteenth?
Steven Lippmann, M.D. Juneteenth What about Juneteenth? This holiday commemorates June 19, 1865, one month after the end of the war between the United States of America and the Confederate States of America. On that day, in Galveston, Texas, US Major General Gordon Granger sailed into the harbor and later delivered a message to Texans […]